Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 1676 to 1700 of 1781 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
2143 Increased, gene expression of AR
0 Molecular May 18, 2023 May 18, 2023 496: Androgen receptor agonism leading to reproduction dysfunction (in zebrafish)
2144 Impaired insulin signaling
0 Cellular May 25, 2023 May 25, 2023 497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
2145 Metabolic syndrome
0 Population May 25, 2023 May 25, 2023 497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
2146 Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
1 Molecular May 25, 2023 Jul 28, 2023
2147 Decreased, Viable Offspring
2 Individual Jun 2, 2023 Apr 10, 2024
2148 Increased LCN2/iron complex binds to SLC22A17 receptor in neuron
0 Molecular Jun 15, 2023 Jun 15, 2023 498: Increased LCN2/iron complex leading to neurological disorders
2149 Increased intracelluar Iron accumulation
0 Cellular Jun 15, 2023 Jun 15, 2023
2150 Neurological disorder
0 Individual Jun 15, 2023 Jun 15, 2023
2151 Disruption, neurotransmitter release
1 Molecular Jun 27, 2023 Jul 21, 2023
2152 Epigenetic modification process
0 Cellular Jul 27, 2023 Jul 27, 2023 503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
2153 Expression of factors ruling proliferation, modified
0 Cellular Jul 27, 2023 Jul 27, 2023 503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
2154 Uterine adenocarcinoma (endometrioid adenocarcinoma Type I)
0 Organ Jul 27, 2023 Jul 27, 2023 503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
2155 Inhibition of Sulfotransferase E1 (SULT1E1)
0 Molecular Jul 28, 2023 Aug 14, 2023 504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
2156 Increased morbidity of congenital heart defect
0 Population Jul 31, 2023 Jul 31, 2023 None
2157 Abnormal Cardiac Structure and Function
0 Organ Jul 31, 2023 Jul 31, 2023 None
2158 Influenza A Virus (IAV) binds sialic acid glycan receptor
1 Molecular Jul 31, 2023 Aug 2, 2023 506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
2159 Influenza A virus (IAV) cell entry
3 Cellular Aug 11, 2023 Oct 3, 2023 506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
2160 Angiogenesis disfunction
0 Organ Aug 19, 2023 Aug 19, 2023 None
2161 Increase, Vascular disrupting effects
0 Individual Aug 19, 2023 Aug 19, 2023
2162 Activation, HIF1α
0 Cellular Aug 20, 2023 Aug 20, 2023 508: Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway
2163 Activation Sema6A
0 Cellular Aug 20, 2023 Aug 20, 2023 508: Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway
2164 Activation, Dll4-Notch pathway
0 Cellular Aug 20, 2023 Aug 20, 2023
2165 Activation of PPAR
0 Cellular Aug 20, 2023 Aug 20, 2023 510: Demethylation of PPAR promotor leading to vascular disrupting effects
2166 Abnormal expression of NO
0 Cellular Aug 20, 2023 Aug 20, 2023 510: Demethylation of PPAR promotor leading to vascular disrupting effects
2167 Activation of MMP-2 MMP-9
0 Cellular Aug 20, 2023 Aug 20, 2023 510: Demethylation of PPAR promotor leading to vascular disrupting effects